GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Onesource Specialty Pharma Ltd

OneSource Specialty Pharma: Dr. Claudio Albrecht's Director Role Changes

MANAGEMENT ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 27 Oct 2026, 10:13 AM IST  ·  BSE ID: 1222ff8e-9a0d-4e02-ae30-93704d052d55
View Original BSE Filing (PDF)
💡
In Simple Terms
A company director, Dr. Claudio Albrecht, will switch roles from an independent to a non-independent director, subject to shareholder vote.
🤖 AI Summary
  • Dr. Claudio Albrecht's designation changed from Independent to Non-Executive Non-Independent Director.
  • Board of Directors approved the change on October 27, 2026.
  • Shareholder approval is required for the designation change to be finalized.
  • The Nomination and Remuneration Committee recommended this change.
🏢 How This Affects the Company
⚠️
Risk Impact
The change in director status may affect board dynamics and future decision-making processes.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders; the change is subject to their future approval.
👤
Who Is Affected
All shareholders will be affected by the change in board composition if shareholder approval is granted.
🔍
Management Signal
This indicates a shift in board governance structure and director independence classification.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Shareholder meeting announcement for director role approval.
Outcome of the shareholder vote on Dr. Albrecht's designation.
Future board minutes detailing Dr. Albrecht's new role.
LOW RISK Standard corporate governance procedure, requiring shareholder confirmation.
💡 Investor Takeaway
Dr. Claudio Albrecht's role shifts from Independent Director to Non-Executive Non-Independent Director, subject to shareholder approval, as decided by the Board on October 27, 2026.
❓ Frequently Asked Questions
What change in designation was approved for Dr. Claudio Albrecht at OneSource Specialty Pharma?
Dr. Claudio Albrecht's designation was approved to change from Independent Director to Non-Executive Non-Independent Director.
When was the change in Dr. Claudio Albrecht's designation approved?
The Board of Directors approved the change in designation on October 27, 2026.
What is required for the change in Dr. Claudio Albrecht's designation to be effective?
The change in designation is subject to the approval of the shareholders of the Company.
Who recommended the change in Dr. Claudio Albrecht's designation?
The Nomination and Remuneration Committee recommended the change in designation to the Board of Directors.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.